Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Liabilities and Shareholders Equity (2016 - 2025)

InspireMD filings provide 16 years of Liabilities and Shareholders Equity readings, the most recent being $69.4 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 48.28% to $69.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $219.9 million, a 12.78% increase, with the full-year FY2025 number at $69.4 million, up 48.28% from a year prior.
  • Liabilities and Shareholders Equity hit $69.4 million in Q4 2025 for InspireMD, down from $78.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $78.5 million in Q3 2025 to a low of $19.9 million in Q1 2023.
  • Median Liabilities and Shareholders Equity over the past 5 years was $44.5 million (2021), compared with a mean of $44.2 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 558.56% in 2021 and later plummeted 43.36% in 2023.
  • InspireMD's Liabilities and Shareholders Equity stood at $39.7 million in 2021, then plummeted by 37.92% to $24.7 million in 2022, then soared by 93.25% to $47.6 million in 2023, then fell by 1.75% to $46.8 million in 2024, then surged by 48.28% to $69.4 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $69.4 million (Q4 2025), $78.5 million (Q3 2025), and $33.3 million (Q2 2025) per Business Quant data.